Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00034853 · ClinicalTrials.gov registry record · Phase 3
Meloxicam [Mobic] in Juvenile Rheumatoid Arthritis (JRA)
A Phase 3 study, sponsored by Boehringer Ingelheim.
- Completed
- Registry status
- Phase 3
- Development phase
- 180
- Enrollment target
NCT00034853: Completed Phase 3 study, sponsored by Boehringer Ingelheim.
NCT00034853 is a Phase 3 study that has completed, run by Boehringer Ingelheim. The registered enrollment target is 180 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (77% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00034853, a Phase 3 study, has completed, sponsored by Boehringer Ingelheim.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 180 participants
- Enrollment target
Study Summary
To obtain safety, efficacy, pharmacokinetic and dosing information for meloxicam oral suspension in children with Juvenile Rheumatoid Arthritis (JRA)
Interventions
- DRUG meloxicam oral suspension
- DRUG naproxen oral suspension
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 180 participants |
| Start Date | 2000-12 |
| Phase | Phase 3 |
What the finished NCT00034853 record still lists
NCT00034853 is an interventional study that assigns participants to a tested intervention. The registered 180 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (77% lower).
The record links to 0 conditions, and to 2 interventions - of which meloxicam oral suspension is the first listed.
NCT00034853 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00034853 about?
NCT00034853 is a clinical study titled "Meloxicam [Mobic] in Juvenile Rheumatoid Arthritis (JRA)". To obtain safety, efficacy, pharmacokinetic and dosing information for meloxicam oral suspension in children with Juvenile Rheumatoid Arthritis (JRA)
What is the current status of trial NCT00034853?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 180 participants. The study started on 2000-12.
What interventions are being tested in trial NCT00034853?
The interventions under investigation include: meloxicam oral suspension (DRUG), naproxen oral suspension (DRUG).
Who is sponsoring clinical trial NCT00034853?
This trial is sponsored by Boehringer Ingelheim, which has 515 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00034853's enrollment target sits among peer trials
180 1422nd of 2000 higher than 564 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01558804 · 180 participants
GRoup A StrePtococcus
- NCT02932176 · 180 participants
Machine Learning for Handheld Vascular Studies
- NCT03384563 · 180 participants · Phase 4
Effect of Dexmedetomidine on the Minimum Alveolar Concentration of Sevoflurane
- NCT03423628 · 180 participants · Phase 1
A Study to Assess the Safety and Tolerability of AZD1390 Given With Radiation Therapy in Patients With Brain Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia